Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure
- PMID: 3707654
Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure
Abstract
Peripheral hemodynamics were studied using strain gauge plethysmography in patients with congestive heart failure after administration of ibopamine (SB-7505), the orally active 3,4-diisobutyryl ester of N-methyldopamine, a dopaminergic agonist, and of sulpiride, a specific dopaminergic antagonist. 50 mg of sulpiride were administered parenterally in 12 patients 3 h after a single oral dose of 150 mg of ibopamine. Ibopamine increased significantly resting arterial blood flow and venous capacity and decreased peripheral resistance. Sulpiride was found to significantly counteract the activity of ibopamine.
Similar articles
-
Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.Arzneimittelforschung. 1986 Feb;36(2A):366-70. Arzneimittelforschung. 1986. PMID: 3707652
-
Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.Arzneimittelforschung. 1986 Feb;36(2A):304-11. Arzneimittelforschung. 1986. PMID: 3707641
-
Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.Arzneimittelforschung. 1986 Feb;36(2A):360-2. Arzneimittelforschung. 1986. PMID: 3707650
-
Pharmacotherapeutic profile of ibopamine in heart failure.J Cardiovasc Pharmacol. 1989;14 Suppl 8:S118-23. J Cardiovasc Pharmacol. 1989. PMID: 2483437 Review.
-
[Ibopamine--clinical results].Z Kardiol. 1991;80 Suppl 8:71-6. Z Kardiol. 1991. PMID: 1686695 Review. German.
Cited by
-
Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.Drugs. 1988 Jul;36(1):11-31. doi: 10.2165/00003495-198836010-00003. Drugs. 1988. PMID: 3063492 Review.
-
Ibopamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in congestive heart failure.Drugs Aging. 1993 Nov-Dec;3(6):556-84. doi: 10.2165/00002512-199303060-00008. Drugs Aging. 1993. PMID: 7906158 Review.
MeSH terms
Substances
LinkOut - more resources
Medical